August 15th, 2022
Ichor Life Sciences Invests $1.5 Million In MitoChem Therapeutics for Ocular Aging Disease Research
Insight
Ichor Life Sciences, a preclinical contract research organization, today announced a $1.5 million investment in MitoChem Therapeutics. Read more: